Abstract
United States Hospital Supplies Medical equipment Industry Report
Summary
This report is an essential source for in-depth information and data relating
to United States hospital supplies medical equipment market. It also offers
detailed and comprehensive coverage of market revenue, volume, distribution
and company share information; and latest news, financial deals and pipeline
products information of each of the key sub-segments of the hospital supplies
medical equipment in United States.
Scope
・ The report provides sector information broken down into detailed categories
and segments in country.
・ Total revenues, products sold, end users, and
average pricing.
・ Market shares of all the key competitors.
・ Key
pipeline products that are set to shape the market, broken down by sector.
・ Information on the top medical equipment companies in the sector in the
country covering business description, strategic analysis, and financial
information.
・ Healthcare structure, regulatory environment, approval
process, pricing trends and reimbursement.
・ Product and brand updates,
strategy changes, R&D projects, corporate expansions and contractions and
regulatory changes.
・ Key mergers and acquisitions, partnerships, private
equity investments and IPOs.
・ Customer, hospitals and physicians
data.
Note: Some content types may not be available in this report
Reasons to buy
・ Gain a strong understanding of the industry at a global level, with break
downs for the country
・ Evaluate and compare the attractiveness of the
market in the country.
・ Identify growth segments and opportunities in
each industry sector within the country.
・ Evaluate the pipeline of key
products that will change the sector, and identify threats and opportunities
before the products are launched in the country.
・ Analyze the
competitiveness of the market in the country and identify hotspots.
・
Develop strategies based on the latest product, brand, expansion and research
and development news in the country.
・ Do deals with an understanding of
how competitors are financed, and the mergers and partnerships that have
shaped the market in the country.
・ Identify and analyze the strengths and
weaknesses of the industry incumbents in the country.
Table of Contents
Table of Contents
1 Table Of Contents 2
1.1 List of Tables 13
1.2 List of Figures 18
2 Introduction 22
2.1 What Is This Report
About? 22
2.2 Definitions 22
2.2.1 Hospital Supplies 22
3
Healthcare Sector Review 25
3.1 Healthcare Expenditure 25
3.2
Healthcare Infrastructure 30
3.2.1 Healthcare Personnel Data 32
3.2.2
Healthcare Facilities Data 36
4 Hospital Supplies in United States 38
4.1 Hospital Supplies Overall Revenues (2000-2012) 38
4.2 Hospital
Supplies Overall Volume (2000-2012) 44
4.3 Hospital Supplies Overall
Company Shares (2005-2006) 46
5 Disposable Hospital Supplies in United
States 47
5.1 Disposable Hospital Supplies Overall Revenues (2000-2012)
47
5.1.1 Gowns and Drapes Overall Revenues (2000-2012) 51
5.1.2 Gloves
Overall Revenues (2000-2012) 53
5.1.3 Procedure kits and Trays Overall
Revenues (2000-2012) 55
5.2 Disposable Hospital Supplies Overall Volume
(2000-2012) 57
5.2.1 Gloves Overall Volume (2000-2012) 58
5.2.2 Gowns
and Drapes Overall Volume (2000-2012) 60
5.2.3 Procedure kits and Trays
Overall Volume (2000-2012) 62
5.3 Disposable Hospital Supplies Average
Price (2000-2012) 64
5.3.1 Gowns and Drapes Average Price (2000-2012)
64
5.3.2 Gloves Average Price (2000-2012) 66
5.3.3 Procedure Kits and
Trays Average Price (2000-2012) 68
5.4 Disposable Hospital Supplies
Distribution Share (2005-2006) 70
5.5 Disposable Hospital Supplies Company
Share (2005-2006) 71
6 Sterilization and Disinfectant Equipment in United
States 72
6.1 Sterilization and Disinfectant Equipment Overall Revenue
72
6.1.1 Physical Sterilization Overall Revenue (2000-2012) 75
6.1.2
Chemical Sterilization Overall Revenue (2000-2012) 77
6.1.3 Radiation
Sterilization Overall Revenue (2000-2012) 79
6.2 Sterilization and
Disinfectant Equipment Overall Volume 81
6.2.1 Physical Sterilization
Overall Volume (2000-2012) 82
6.2.2 Chemical Sterilization Overall Volume
(2000-2012) 84
6.2.3 Radiation Sterilization Overall Volume (2000-2012)
86
6.3 Sterilization and Disinfectant Equipment Average Price 88
6.3.1
Physical Sterilization Average Price (2000-2012) 88
6.3.2 Chemical
Sterilization Average Price (2000-2012) 90
6.3.3 Radiation Sterilization
Average Price (2000-2012) 92
6.4 Sterilization and Disinfectant Equipment
Distribution Share 93
6.5 Sterilization and Disinfectant Equipment Company
Share 95
7 Syringes and Needles in United States 96
7.1 Syringes and
Needles Overall Revenue (2000-2012) 96
7.1.1 Specialized Syringes Overall
Revenue (2000-2012) 100
7.1.2 General Syringes Overall Revenue (2000-2012)
102
7.2 Syringes and Needles Category Volume (2000-2012) 104
7.2.1
General Syringes Overall Volume (2000-2012) 106
7.2.2 Specialized Syringes
Overall Volume (2000-2012) 108
7.3 Syringes and Needles Average Price
110
7.3.1 General Syringes Average Price (2000-2012) 110
7.3.2
Specialized Syringes Average Price (2000-2012) 112
7.4 Syringes and
Needles Distribution Share (2005-2006) 113
7.5 Syringes and Needles
Company Share 114
8 Mobility Aids and Transportation Equipment in United
States 115
8.1 Mobility Aids and Transportation Equipment Overall Revenue
(2000-2012) 115
8.1.1 Wheelchairs Overall Revenue (2000-2012) 119
8.1.2 Stretchers Overall Revenue (2000-2012) 121
8.2 Mobility Aids and
Transportation Equipment Overall Volume 123
8.2.1 Wheelchairs Overall
Volume (2000-2012) 125
8.2.2 Stretchers Overall Volume (2000-2012) 127
8.3 Mobility Aids and Transportation Equipment Average Price 129
8.3.1
Wheelchairs Average Price (2000-2012) 129
8.3.2 Stretchers Average Price
(2000-2012) 131
8.4 Mobility Aids and Transportation Equipment
Distribution Share 133
8.5 Mobility Aids and Transportation Equipment
Company Share 134
9 Patient Examination Devices in United States 135
9.1 Patient Examination Devices Overall Revenue (2000-2012) 135
9.1.1
Thermometer Overall Revenue (2000-2012) 139
9.1.2 Stethoscope Overall
Revenue (2000-2012) 141
9.2 Patient Examination Devices Overall Volume
(2000-2012) 143
9.2.1 Thermometer Overall Volume (2000-2012) 145
9.2.2
Stethoscope Overall Volume (2000-2012) 147
9.3 Patient Examination Devices
Average Price (2000-2012) 149
9.3.1 Thermometer Average Price (2000-2012)
149
9.3.2 Stethoscope Average Price (2000-2012) 151
9.4 Patient
Examination Devices Distribution Share 153
9.5 Patient Examination Devices
Company Share (2005-2006) 154
10 3M Company Profile 155
10.1 Company
Overview 155
10.2 Business Overview 155
10.2.1 Consumer and Office
155
10.2.2 Display and Graphics 155
10.2.3 Electro and Communications
156
10.2.4 Health Care 156
10.2.5 Industrial and Transportation
157
10.2.6 Safety, Security and Protection Services 158
10.2.7
Products 158
10.3 Value Chain Analysis 160
10.3.1 Manufacturing
160
10.3.2 Product Development 161
10.3.3 Sales and Marketing 161
10.4 SWOT Analysis 162
10.4.1 3M Company Strengths 162
10.4.2 3M
Company Weaknesses 163
10.4.3 3M Company Opportunities 163
10.4.4 3M
Company Threats 164
10.5 Financial and Operational Review 165
10.6
Locations And Subsidiaries 167
10.7 Financial Deals Landscape 168
10.7.1 3M Canada Acquires Les Entreprises Solumed 168
10.7.2 3M Acquires
Bondo 169
10.7.3 3M Acquires Lingualcare 171
10.7.4 3M Acquires Abzil
Industria E Comercio 173
10.7.5 3M Acquires Neo Plast 175
10.7.6 3M
Acquires Assets Of DMS Chile 177
10.7.7 3M Acquires Business Of Innovative
Paper Technologies 179
10.7.8 3M Acquires Powell 181
10.7.9 Gen-Probe
Signs An Agreement With 3M Company 183
10.7.10 3M Acquires Acolyte
Biomedica 185
10.7.11 3M Acquires Sealed Air Corp.' S Interest In Polymask
Corp. 187
10.7.12 3M Sells Its Pharmaceutical Business To Meda AB 189
10.7.13 3M Acquires SoftMed Systems 191
10.7.14 3M Sells its
Pharmaceuticals Business to Graceway 193
10.7.15 Gen-Probe Signs An
Agreement With 3M 195
10.7.16 3M Sells its Pharmaceutical Operations in
the Asia Pacific Region to Ironbridge Capital and Archer Capital 197
10.7.17 3M Acquires Biotrace International 199
10.7.18 Ekahau Secures $16
Million In Additional Funding 201
10.7.19 3M Acquires Brontes Technologies
204
10.7.20 3M acquires Nylonge Corp 206
10.7.21 3M Signs An Agreement
With ClozeX Medical 208
10.7.22 3M Acquires OMNII Oral Pharmaceuticals
210
10.7.23 3M Sells Pharmaceutical Operations In The United States To
Graceway 212
10.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB
214
10.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To
Ironbridge and Archer Capital 217
10.7.26 3M Acquires Accuspray
Application Technologies Inc. 220
10.7.27 3M to acquire Rochford Thompson
Equipment 221
10.7.28 3M To Acquire Aearo Technologies From Permira
223
10.7.29 Permira To Sell Aearo Technologies To 3M 226
10.8 Recent
Developments 228
10.8.1 Mar 31, 2008: HighJump Software Introduces Survey
Management Solution for Direct Store Delivery Businesses 228
10.8.2 Mar
24, 2008: Brazil' s Companhia de Transmissao de Energia Eletrica Paulista
Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State
229
10.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in
Asia 230
10.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business
In North Asia 230
10.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th
Straight Year 230
10.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend
230
10.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery
231
10.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend 231
10.8.9 May
08, 2007: 3M Declares Quarterly Dividend 231
10.8.10 Apr 30, 2007:
Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests 231
11
Getinge AB Company Profile 232
11.1 Company Overview 232
11.2 Business
Overview 232
11.2.1 Extended Care 232
11.2.2 Infection Control 232
11.2.3 Medical Systems 233
11.2.4 Products 233
11.2.5 History 234
11.3 Value Chain Analysis 237
11.3.1 Manufacturing 237
11.3.2 Product
Development 237
11.3.3 Sales and Marketing 238
11.4 SWOT Analysis
238
11.4.1 Getinge AB Strengths 238
11.4.2 Getinge AB Weaknesses
239
11.4.3 Getinge AB Opportunities 240
11.4.4 Getinge AB Threats
241
11.5 Financial and Operational Review 242
11.6 Locations And
Subsidiaries 244
11.7 Financial Deals Landscape 246
11.7.1 Boston
Scientific Sells Cardiac Surgery And Vascular Surgery Businesses To Getinge
Group 246
11.7.2 MAQUET do Brasil Acquires Comercio e Industria Medica
247
11.7.3 Getinge Acquires Lancer UK 248
11.7.4 Getinge Acquires La
Calhene Group 249
11.7.5 Getinge Acquires Dynamed 250
11.7.6 Getinge
Acquires BHM Medical 251
12 Cardinal Health, Inc. 252
12.1 Company
Overview 252
12.2 Business Overview 252
12.2.1 Clinical Technologies
and Services 252
12.2.2 Medical Products and Services 252
12.2.3
Pharmaceutical Distribution and Provider Services 253
12.2.4
Pharmaceutical Technologies and Services 253
12.2.5 Products 254
12.2.6 History 254
12.3 Value Chain Analysis 258
12.3.1 Manufacturing
258
12.3.2 Product Development 259
12.3.3 Sales and Marketing 259
12.4 SWOT Analysis 260
12.4.1 Cardinal Health, Inc. Strengths 260
12.4.2 Cardinal Health, Inc. Weaknesses 261
12.4.3 Cardinal Health, Inc.
Opportunities 261
12.4.4 Cardinal Health, Inc. Threats 262
12.5
Financial and Operational Review 264
12.6 Locations And Subsidiaries
266
12.7 Financial Deals Landscape 268
12.7.1 Cardinal Health Signs An
Agreement With ClearCount Medical Solutions 268
12.7.2 Cardinal Health And
Alliance Boots Forms A Joint Venture 268
12.7.3 Cardinal Health Signs An
Agreement With Hemcon Medical Technologies 269
12.7.4 Cardinal Health
Acquires VIASYS Healthcare 270
12.7.5 Cardinal Health Sells Its
Pharmaceutical Technologies And Services Segment To The Blackstone Group
271
12.7.6 Platinum Equity Completes Acquisition Of Healthcare Marketing
Services Unit From Cardinal Health 273
12.7.7 Cardinal Health Enters Into
Distribution Agreement With Fisher & Paykel 273
12.7.8 Cardinal Health And
Surgicount Enter Into Co-Marketing Agreement 274
12.7.9 Cardinal Health
Acquires Care Fusion 275
12.7.10 Cardinal Health Acquires Medmined 276
12.7.11 Cardinal Health Acquires PET Radiopharmaceutical Production Facilities
From Regional Nuclear Pharmaceuticals 277
12.7.12 Cardinal Health Acquires
Wholesale Distribution Businesses From F. Dohmen 278
12.7.13 Cardinal
Health Acquires Denver Biomedical 279
12.7.14 Cardinal Health Signs An
Agreement With Eisai 280
12.7.15 Cardinal Health Enters Into A
Distribution Agreement With Eli Lilly 281
12.7.16 Cardinal Health Enters
Into An Agreement With Monogen 282
12.7.17 Cardinal Health Acquires ALARIS
Medical Systems 283
12.7.18 Microtek Medical Acquires Certain Businesses
Of International Medical And Affiliates From Cardinal 284
12.7.19 Bespak
Enters Into A Co-Marketing Agreement With Cardinal Health 285
12.7.20
Platinum Equity To Acquire Healthcare Marketing Services Unit Of Cardinal
Health 285
12.7.21 Cardinal Health To Acquire Enturia 286
12.8 Recent
Developments 287
12.8.1 Apr 01, 2008: Cardiac Science signs letter of
intent with Misys Healthcare Systems to connect with their EMR systems 287
12.8.2 Mar 18, 2008: Cardinal Appoints New Chief Compliance Officer 288
12.8.3 Mar 13, 2008: Cardinal Names President To Its Pharmaceutical Segment
289
12.8.4 Feb 20, 2008: Cardiac Science Corporation Schedules Fourth
Quarter Earnings Release and Announces Conference Call 289
12.8.5 Sep 24,
2007: Cardinal Names CEO As Chairman 290
12.8.6 Aug 08, 2007: Cardinal
Health Elects New Director To The Board 290
12.8.7 Aug 08, 2007: Cardinal
Health Declares Quarterly Dividend 290
12.8.8 Aug 08, 2007: Cardinal
Health Announces Share Repurchase Program 291
12.8.9 May 02, 2007:
Cardinal Health Elects New Director 291
12.8.10 May 02, 2007: Cardinal
Health Increases Quarterly Dividend 291
12.8.11 Jan 31, 2007: Cardinal
Health Declares Quarterly Dividend 291
12.8.12 Jan 31, 2007: Cardinal
Health Announces Share Repurchase 291
12.8.13 Nov 10, 2006: Cardinal
Health Names New CEO For Healthcare Supply Chain Services 291
12.8.14 Nov
08, 2006: Cardinal Health Declares Quarterly Dividend 292
12.8.15 Nov 08,
2006: Cardinal Health Names New Director 292
12.8.16 Aug 03, 2006:
Cardinal Health Announces Share Repurchase Program 292
12.8.17 Aug 02,
2006: Cardinal Health Declares Quarterly Dividend 292
12.8.18 Jul 17,
2006: Cardinal Health Signs Agreement With Premier 292
12.8.19 Jun 12,
2006: Cardinal Health Announces Fiscal 2007 Outlook 293
12.8.20 May 10,
2006: Cardinal Health Raises Quarterly Dividend By 50% 293
12.8.21 Apr 17,
2006: Cardinal Health President and COO Leaves 293
12.8.22 Apr 17, 2006:
Cardinal Health Appoints New President, CEO and Director 293
13 Invacare
Corporation Company Profile 294
13.1 Company Overview 294
13.2
Business Overview 294
13.2.1 Asia / Pacific 294
13.2.2 Europe 294
13.2.3 Institutional Products Group 295
13.2.4 Invacare Supply Group
295
13.2.5 North America / HME 296
13.2.6 Products 296
13.2.7
History 297
13.3 Value Chain Analysis 299
13.3.1 Manufacturing 299
13.3.2 Product Development 300
13.3.3 Sales and Marketing 300
13.4
SWOT Analysis 301
13.4.1 Invacare Corporation Strengths 301
13.4.2
Invacare Corporation Weaknesses 302
13.4.3 Invacare Corporation
Opportunities 303
13.4.4 Invacare Corporation Threats 303
13.5
Financial and Operational Review 305
13.6 Locations And Subsidiaries
307
13.7 Financial Deals Landscape 309
13.7.1 Invacare Completes
Private Placement Of Convertible Senior Subordinated Debentures 309
13.7.2
Invacare Completes Private Placement Of Senior Notes 310
13.7.3 Invacare
Acquires Wp Domus 311
13.8 Recent Developments 312
13.8.1 Mar 06,
2008: Invacare Appoints New CFO 312
13.8.2 Jan 15, 2008: Invacare CFO To
Resign, Appoints Interim CFO 312
13.8.3 Nov 16, 2007: Invacare Declares
Quarterly Dividend 312
13.8.4 Aug 22, 2007: Invacare Declares Quarterly
Dividend 312
13.8.5 May 24, 2007: Invacare Declares Quarterly Dividend
312
13.8.6 Feb 09, 2007: Invacare Declares Quarterly Dividend 313
13.8.7 Nov 21, 2006: Invacare Declares Quarterly Dividend 313
14
Kimberly-Clark Corporation Company Profile 314
14.1 Company Overview
314
14.2 Business Overview 314
14.2.1 Consumer Tissue 314
14.2.2
Healthcare 314
14.2.3 K-C Professional & Other 315
14.2.4 Personal
Care 315
14.2.5 Products 316
14.2.6 History 317
14.3 Value Chain
Analysis 320
14.3.1 Manufacturing 320
14.3.2 Product Development
320
14.3.3 Sales and Marketing 321
14.4 SWOT Analysis 322
14.4.1
Kimberly-Clark Corporation Strengths 322
14.4.2 Kimberly-Clark Corporation
Weaknesses 323
14.4.3 Kimberly-Clark Corporation Opportunities 323
14.4.4 Kimberly-Clark Corporation Threats 323
14.5 Financial and
Operational Review 325
14.6 Locations And Subsidiaries 327
14.7
Financial Deals Landscape 329
14.7.1 Kimberly-Clark Increases Its
Ownership In Brazilian Affiliate To 100% 329
14.7.2 Kimberly-Clark
Acquires Microcuff 330
14.7.3 Betty Mills Partners with Kimberly-Clark
Professional 330
14.8 Recent Developments 331
14.8.1 Mar 06, 2008:
Kimberly-Clark Announces Management Changes 331
14.8.2 Feb 21, 2008:
Kimberly-Clark Approves Quarterly Dividend 332
14.8.3 Nov 14, 2007:
Kimberly-Clark Declares Quarterly Dividend 332
14.8.4 Aug 01, 2007:
Kimberly-Clark Declares Quarterly Dividend 332
14.8.5 Jul 25, 2007:
Kimberly-Clark Elects New Board Member 332
14.8.6 Apr 26, 2007:
Kimberly-Clark Declares Quarterly Dividend 333
14.8.7 Apr 02, 2007:
Kimberly-Clark Announces New Global Marketing Structure 333
14.8.8 Mar 19,
2007: Kimberly-Clark Announces President 335
14.8.9 Feb 21, 2007:
Kimberly-Clark Announces Increase In Dividend 335
14.8.10 Feb 15, 2007:
Kimberly-Clark Announces CIO 336
14.8.11 Jan 29, 2007: Kimberly-Clark
Signs Agreement With Accenture 336
14.8.12 Jan 16, 2007: Kimberly-Clark
Signs Agreement With Cognizant 337
14.8.13 Jan 16, 2007: Kimberly-Clark
Signs Agreement With TCS 337
14.8.14 Jan 08, 2007: Kimberly-Clark Signs
Agreement With ICG Commerce 338
14.8.15 Jan 08, 2007: Kimberly-Clark Signs
Contract With Genpact 338
14.8.16 Nov 15, 2006: Kimberly-Clark Elects
Board Member 339
14.8.17 Nov 15, 2006: Kimberly-Clark Declares Quarterly
Dividend 339
14.8.18 Sep 21, 2006: Kimberly-Clark Announces CMO 339
14.8.19 Sep 20, 2006: Kimberly-Clark To Establish Innovation Center In South
Korea 340
14.8.20 Aug 01, 2006: Kimberly-Clark Declares Quarterly Dividend
342
15 Regulation System 343
15.1 Medical Equipment Approval Process
343
15.1.1 Pre-market Approval Process 344
15.1.2 Intended use and
Indications for use 344
15.1.3 Predicate Device 344
15.1.4 Safe and
Effective 345
15.1.5 Other Category Devices 347
15.1.6 Post-Market
Approval Process 348
15.1.7 Compliance and Enforcement 348
15.1.8
Registration Fee 349
15.1.9 Approval Time 349
16 Pricing and
Reimbursement 350
16.1 Government Policies 350
16.2 Private Insurance
351
16.3 Diagnosis Related Groups (DRG) 352
17 Distribution Structure
353
17.1 Distribution Structure 353
18 APPENDIX 354
18.1
Methodology 354
18.2 Currency Conversion 355
18.3 Contact Us 356
18.4 Disclaimer 356
